Statera Biopharma, Inc. Retained Earnings
Statera Biopharma, Inc. had Retained Earnings of -$144.08 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-11-14
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$144.08M.
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$140.73M.
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$137.24M.
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$129.48M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2022-09-30 | -$144.08M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$140.73M 10-Q · filed 2022-10-28 | |
| 2022-03-31 | -$137.24M 10-Q · filed 2022-10-21 | |
| 2021-12-31 | -$129.48M 10-Q · filed 2022-11-14 | |
| 2021-09-30 | -$52.26M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$170.30M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$169.64M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$169.10M 10-Q · filed 2021-08-16 | |
| 2020-12-30 | -$27.76M 10-Q · filed 2021-11-15 | |
| 2020-09-30 | -$168.41M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$167.66M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$167.29M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$166.71M 10-K · filed 2021-03-22 | -$167.17M 10-K · filed 2020-04-15 |
| 2019-09-30 | -$166.00M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$165.55M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$164.93M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$164.06M 10-K · filed 2020-04-15 | |
| 2018-09-30 | -$163.63M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | -$162.52M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$161.67M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$160.45M 10-K · filed 2019-03-07 | |
| 2017-09-30 | -$159.28M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$158.02M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$152.40M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$150.74M 10-K · filed 2018-03-06 | |
| 2016-09-30 | -$149.51M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$150.65M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$148.65M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$147.98M 10-K · filed 2017-02-22 | |
| 2015-09-30 | -$145.83M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$142.71M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | -$138.26M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$133.94M 10-K · filed 2016-02-23 | |
| 2014-09-30 | -$145.21M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$141.11M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$137.15M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$135.56M 10-K · filed 2015-02-27 | |
| 2013-09-30 | -$135.20M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | -$131.11M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | -$128.07M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$118.30M 10-K · filed 2014-03-17 | |
| 2012-09-30 | -$121.41M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | -$110.53M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | -$105.45M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | -$100.07M 10-K · filed 2013-03-18 | |
| 2011-09-30 | -$92.88M 10-Q/A · filed 2011-11-14 | |
| 2011-06-30 | -$90.18M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | -$96.05M 10-K · filed 2012-03-13 |